These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7751047)

  • 61. Cytogenetic analysis of hematologic malignancies in Hong Kong. A study of 98 cases.
    Chan LC; Kwong YL; Liu HW; Chan TK; Todd D; Ching LM
    Cancer Genet Cytogenet; 1992 Sep; 62(2):154-9. PubMed ID: 1394102
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis.
    Horiike S; Taniwaki M; Misawa S; Abe T
    Cancer; 1988 Sep; 62(6):1129-38. PubMed ID: 3409186
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cytogenetic studies in 69 patients with myelodysplastic syndromes (MDS).
    Weh HJ; Calavrezos A; Seeger D; Kuse R; Hossfeld DK
    Eur J Haematol; 1987 Feb; 38(2):166-72. PubMed ID: 3595811
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Re-emergence in remission of primary clone in acute myelogenous leukaemias with multiple chromosomal aberrations at diagnosis.
    Heim S; Sørensen AG; Christensen BE; Pedersen NT
    Br J Haematol; 1992 Oct; 82(2):332-6. PubMed ID: 1419815
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7.
    Crisà E; Kulasekararaj AG; Adema V; Such E; Schanz J; Haase D; Shirneshan K; Best S; Mian SA; Kizilors A; Cervera J; Lea N; Ferrero D; Germing U; Hildebrandt B; Martínez ABV; Santini V; Sanz GF; Solé F; Mufti GJ
    Leukemia; 2020 Sep; 34(9):2441-2450. PubMed ID: 32066866
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Could the mosaic pattern of chromosomal abnormality predict overall survival of patients with myelodysplastic syndrome?
    Uyanik MS; Demir AM; Kurt I; Maden M; Oz Puyan F; Gurkan H; Umit EG; Pamuk GE
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):41-7. PubMed ID: 26806462
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clonal evolution in primary 5q-syndrome.
    Wong KF; Chan JK; Chu YC; Kwong YL
    Cancer; 1992 Jul; 70(1):100-3. PubMed ID: 1606529
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings.
    Rigolin GM; Cuneo A; Roberti MG; Bardi A; Bigoni R; Piva N; Minotto C; Agostini P; De Angeli C; Del Senno L; Spanedda R; Castoldi G
    Br J Haematol; 1998 Oct; 103(1):189-97. PubMed ID: 9792307
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Two myelodysplastic syndrome cases with the inv(11)(p15q23) as a sole chromosomal abnormality.
    Mitani K; Sato Y; Hayashi Y; Miura Y; Miyagawa K; Yazaki Y; Hirai H
    Br J Haematol; 1992 Aug; 81(4):512-5. PubMed ID: 1390237
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells.
    Kotini AG; Chang CJ; Boussaad I; Delrow JJ; Dolezal EK; Nagulapally AB; Perna F; Fishbein GA; Klimek VM; Hawkins RD; Huangfu D; Murry CE; Graubert T; Nimer SD; Papapetrou EP
    Nat Biotechnol; 2015 Jun; 33(6):646-55. PubMed ID: 25798938
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome.
    Nakagawa T; Matozaki S; Murayama T; Nishimura R; Tsutsumi M; Kawaguchi R; Yokoyama Y; Hikiji K; Isobe T; Chihara K
    Br J Haematol; 1993 Nov; 85(3):469-76. PubMed ID: 8136267
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Myelodysplastic syndrome with karyotype abnormality is associated with elevated F-cell production.
    Craig JE; Sampietro M; Oscier DG; Contreras M; Thein S
    Br J Haematol; 1996 Jun; 93(3):601-5. PubMed ID: 8652380
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromes.
    Swolin B; Kristiansen IH; Rödjer S; Hellström-Lindberg E
    Leuk Res; 1993 Nov; 17(11):927-32. PubMed ID: 8231233
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Chromosome studies in 20 cases of myelodysplastic syndrome].
    Hou M; Deng CA; Ruan HF
    Hua Xi Yi Ke Da Xue Xue Bao; 1987 Dec; 18(4):368-71. PubMed ID: 3449428
    [No Abstract]   [Full Text] [Related]  

  • 75. Myelodysplastic syndrome after regression of transient abnormal myelopoiesis in a Down syndrome infant: different clonal origin?
    Kounami S; Aoyagi N; Tsuno H; Suzuki H; Kobayashi M; Koike M
    Cancer Genet Cytogenet; 1998 Jul; 104(2):115-8. PubMed ID: 9666804
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Another case of myelodysplastic syndrome with a chromosome mode in the tetraploid range.
    Pedersen B; Kerndrup G
    Cancer Genet Cytogenet; 1986 Oct; 23(2):175-8. PubMed ID: 3756837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Oncogenes in the myelodysplastic syndrome.
    Jacobs A
    Blood Rev; 1989 Jun; 3(2):105-9. PubMed ID: 2673442
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Array comparative genomic hybridization analysis of myelodysplastic syndromes with complex karyotypes. A technical evaluation.
    Martínez-Ramírez A; Urioste M; Calasanz MJ; Cigudosa JC; Benítez J
    Cancer Genet Cytogenet; 2003 Jul; 144(1):87-9. PubMed ID: 12810265
    [No Abstract]   [Full Text] [Related]  

  • 79. Unusual case of a myelodysplastic syndrome with novel inv(5)(q15q33).
    Golden RJ; Bogusz AM
    Blood; 2019 Jun; 133(24):2624. PubMed ID: 31196879
    [No Abstract]   [Full Text] [Related]  

  • 80. Letter: International registry of abnormal karyotypes.
    Borgaonkar DS; Bolling DR
    JAMA; 1975 Jun; 232(11):1125. PubMed ID: 1173608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.